Search
Descriptor in English: Panobinostat
Descriptor in Spanish: Panobinostat
Descriptor in Portuguese: Panobinostat
Descriptor in French: Panobinostat
Entry term(s): Farydak
LBH 589
LBH589
NVP LBH589
NVP-LBH589
Tree number(s): D02.092.570.394.535
D02.241.511.372.535
D03.633.100.473.746
Scope note: An indole and hydroxamic acid derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used as an antineoplastic agent in combination with BORTEZOMIB and DEXAMETHASONE for the treatment of MULTIPLE MYELOMA.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
History Note: 2019 (2005)
DeCS UI: 57746
Descriptor UI: D000077767
Date Established: 2019/01/01
Date of Entry: 2018/07/09
Revision Date: 2018/05/21
Panobinostat - Preferred
Concept UI M0540392
Scope note An indole and hydroxamic acid derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used as an antineoplastic agent in combination with BORTEZOMIB and DEXAMETHASONE for the treatment of MULTIPLE MYELOMA.
Preferred term Panobinostat
LBH589 - Narrower
Concept UI M0481330
Preferred term LBH589
Entry term(s) LBH 589
NVP LBH589
NVP-LBH589
Farydak - Narrower
Concept UI M000602770
Preferred term Farydak



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.


Go to survey